Oncofertility

Oncofertility is the field of medicine that focuses on protecting fertility in people who have cancer or who need treatments that may harm the reproductive system. In men’s health, it usually means understanding how chemotherapy, radiation, surgery, and certain medications can affect sperm production, testosterone, ejaculation, and the ability to have biological children in the future. The goal is simple but time-sensitive: address fertility risks before treatment starts whenever possible.

What Is Oncofertility?
Why Oncofertility Matters
What Oncofertility Means in Men's Health
Who May Need Oncofertility Care?
How Cancer Treatment Can Affect Fertility
Symptoms and Signs of Fertility Problems After Cancer Treatment
Testing and Evaluation
What's Normal vs What's Not?
Fertility Preservation Options for Men and Boys
Comparison of Fertility Preservation Options
Treatment and Management After Treatment
Why Timing Is Critical
Questions to Ask Your Doctor
Common Myths and Misconceptions
Related Tests and Terms
Frequently Asked Questions
References

What Is Oncofertility?

Oncofertility combines oncology and fertility medicine. It is an area of care devoted to preserving the chance of future parenthood in patients facing cancer treatment. The term is often used for women and men, adults and children, but in men it commonly involves sperm banking, fertility risk counseling, hormone and semen testing, and longer-term follow-up after treatment.

Professional organizations including the American Society of Clinical Oncology (ASCO) and the American Society for Reproductive Medicine (ASRM) recommend discussing fertility risks and preservation options as early as possible for patients who may receive gonadotoxic therapy. That matters because some options are easiest, safest, and most effective before treatment begins.

Oncofertility at a glance

It addresses how cancer and cancer treatment can affect fertility.
It includes counseling, testing, sperm preservation, and reproductive planning.
It is relevant before, during, and after treatment.
It can apply to adult men, adolescent boys, and prepubertal boys, although options differ by age.
It is not only about sperm count; it can also involve hormones, ejaculation, erections, and long-term reproductive health.

Why Oncofertility Matters

Cancer survival has improved significantly, which means quality of life after treatment matters more than ever. For many patients, fertility is not a minor issue. It can affect future family-building options, identity, relationships, and mental health. Research and guideline statements have repeatedly shown that fertility discussions are a core part of good cancer care, not an optional extra. ASCO highlights fertility preservation counseling as a standard part of management for reproductive-age patients receiving potentially gonadotoxic therapy ASCO guideline update.

Even when parenthood feels far away, decisions made in the days before treatment can have lifelong consequences. Many fertility problems after cancer treatment are not obvious right away. A man may still have normal sexual function but reduced sperm production. Others may recover partially over time, while some do not. That uncertainty is one reason early planning matters.

Key takeaways

Some cancer treatments can lower sperm count temporarily or permanently.
Fertility can be affected even if erections and libido remain normal.
Sperm banking before treatment is often the simplest preservation option for post-pubertal males.
Risk depends on the cancer type, treatment type, dose, radiation field, and baseline fertility.
Testicular cancer and blood cancers can affect fertility even before treatment starts.
Recovery may take months or years, and sometimes does not fully occur.
If preserving fertility matters to you, ask before treatment begins.

What Oncofertility Means in Men's Health

In men’s health, oncofertility usually centers on protecting or assessing:

Spermatogenesis — the process of making sperm
Semen quality — sperm concentration, motility, morphology, and volume
Hormonal function — especially testosterone production and pituitary signaling
Testicular function — both sperm-producing and hormone-producing roles
Sexual function — erection, ejaculation, libido, and orgasm
Future reproductive planning — natural conception, IUI, IVF, or ICSI

This distinction matters because fertility and sexual function are related but not identical. A man may have normal erections and still have azoospermia, severe oligospermia, or DNA damage in sperm. Likewise, a man may have low testosterone after treatment but still produce sperm, although hormone patterns can complicate recovery and fertility planning.

Who May Need Oncofertility Care?

Oncofertility care may be relevant to any male patient whose disease or treatment could impair reproductive function. This includes, but is not limited to:

Men with testicular cancer
Men with lymphoma or leukemia
Men with sarcoma
Men with brain tumors or tumors near hormone-regulating structures
Men receiving chemotherapy, especially alkylating agents
Men receiving pelvic, testicular, or total body radiation
Men undergoing surgery that could affect ejaculation, testes, or reproductive anatomy
Patients preparing for stem cell transplant
Adolescent boys and young adults needing gonadotoxic therapy

Oncofertility is also relevant outside classic cancer care. Some non-cancer treatments, such as certain conditioning regimens for transplant or therapies for autoimmune disease, can also be gonadotoxic. In practice, the same fertility-preservation principles may apply.

How Cancer Treatment Can Affect Fertility

Fertility can be affected by the cancer itself, the treatment, or both. The testes contain rapidly dividing germ cells, which makes sperm production particularly vulnerable to toxic exposures. Different treatments affect fertility in different ways.

Chemotherapy

Some chemotherapy drugs damage the cells involved in sperm production. Alkylating agents are especially known for this risk. Depending on the drug, dose, and cumulative exposure, chemotherapy may cause temporary low sperm count, prolonged severe oligospermia, or permanent azoospermia. Reviews in reproductive oncology have consistently identified treatment intensity as a major determinant of recovery review on fertility preservation in males with cancer.

Radiation therapy

Radiation can harm sperm-producing tissue directly, especially if the testes are in or near the treatment field. Scatter radiation can also affect the testes even when they are not the target. Higher doses increase the risk of long-term or permanent impairment. Radiation to the brain can affect the hypothalamus or pituitary and disrupt reproductive hormones, indirectly impairing fertility.

Surgery

Surgical treatment may affect fertility if it involves the testes, prostate, retroperitoneum, pelvis, or nerves important for ejaculation. Examples include orchiectomy for testicular cancer, retroperitoneal lymph node dissection, or pelvic surgery that causes retrograde ejaculation or anejaculation. Having one testicle removed does not automatically cause infertility, but baseline sperm production, the health of the remaining testis, and treatment history all matter.

Stem cell transplantation

Conditioning regimens used before hematopoietic stem cell transplant often include high-dose chemotherapy and sometimes total body irradiation. These regimens carry a particularly high risk of long-term infertility.

Hormonal effects

Some cancers and treatments affect Leydig cell function, testosterone production, or pituitary signaling. That can lead to symptoms of hypogonadism, delayed recovery, or impaired overall reproductive health. The NICHD overview of male infertility notes that hormone problems are one possible cause of reduced fertility and may require targeted evaluation.

Can cancer itself affect sperm before treatment?

Yes. Certain cancers, especially testicular cancer, lymphoma, and leukemia, have been associated with reduced semen quality even before therapy begins. Fever, inflammation, poor general health, endocrine disruption, and underlying testicular dysfunction may all play a role. This is one reason sperm banking is often recommended as early as possible after diagnosis, not after the first treatment cycle.

Symptoms and Signs of Fertility Problems After Cancer Treatment

There may be no obvious symptoms of impaired fertility. Many men only discover a problem when trying to conceive. When symptoms do occur, they may include:

Difficulty achieving pregnancy with a partner after 6 to 12 months of trying, depending on age and circumstances
Low or absent sperm count on semen analysis
Reduced ejaculate volume
Changes in ejaculation, including dry ejaculation or retrograde ejaculation
Testicular atrophy or a feeling that the testicles are smaller
Low libido, fatigue, or other symptoms suggestive of low testosterone
Erectile dysfunction after pelvic surgery, radiation, or major illness

Importantly, none of these signs alone can confirm infertility. Formal evaluation is often needed.

Testing and Evaluation

Oncofertility assessment may happen before treatment, after treatment, or both. The exact workup depends on age, urgency, cancer type, and whether the goal is preservation or evaluation of current fertility.

Common tests used in male oncofertility

Semen analysis — evaluates sperm concentration, motility, morphology, semen volume, and related parameters
Hormone testing — often includes total testosterone, FSH, LH, and sometimes estradiol or prolactin
Physical exam — testicular size, varicocele, signs of androgen deficiency, pubertal development
Medical history review — cancer diagnosis, treatment plan, prior fertility, medications, fevers, surgeries
Specialized sperm retrieval assessment — if ejaculation is not possible or sperm are absent from the ejaculate

What test measures fertility most directly?

For most adult men, the starting test is a semen analysis. The World Health Organization publishes laboratory guidance for semen evaluation, and these values help frame interpretation, although fertility cannot be reduced to one number alone WHO Laboratory Manual for the Examination and Processing of Human Semen.

When should testing be done?

Before treatment if fertility preservation is being considered
During survivorship follow-up when planning future conception
After treatment once adequate recovery time has passed, often guided by the oncology and fertility teams

Immediate post-treatment semen testing may not reflect long-term recovery potential, so timing should be individualized.

What's Normal vs What's Not?

In oncofertility, there is no single universal “normal” benchmark because the key question is often future reproductive potential rather than a diagnosis made from one isolated result. Still, some patterns are commonly used to guide discussion.

General interpretation

Potentially reassuring: sperm present in the ejaculate, reasonable motility, and no major hormone abnormalities
Concerning: azoospermia, severe oligospermia, marked motility problems, or lab evidence of gonadal or pituitary dysfunction
Context matters: one abnormal test does not always mean permanent infertility

Examples of findings and what they may suggest

Azoospermia: no sperm seen in semen; may be temporary or permanent after treatment, or due to obstruction or ejaculatory issues
Oligospermia: low sperm concentration; may reduce chance of natural conception but does not make pregnancy impossible
Low semen volume: may suggest incomplete collection, ejaculatory dysfunction, retrograde ejaculation, or accessory gland issues
High FSH: can suggest impaired testicular sperm production
Low testosterone: may signal Leydig cell dysfunction or hypothalamic-pituitary effects

Finding	What It May Mean	Why It Matters
Sperm present before treatment	Fertility preservation by banking is often possible	Can create future options before gonadotoxic therapy
Azoospermia after treatment	No sperm seen in ejaculate	May require repeat testing or sperm retrieval discussion
Low testosterone	Hormonal function may be impaired	Can affect symptoms, sexual health, and overall wellbeing
High FSH	Possible testicular damage affecting sperm production	May suggest reduced recovery potential, though not definitive
Retrograde or absent ejaculation	Ejaculatory pathway or nerve issue	Can impair fertility even if sperm production continues

A reproductive urologist or fertility specialist can help interpret results in the context of treatment history.

Fertility Preservation Options for Men and Boys

The best option depends on age, puberty status, diagnosis, urgency, ability to ejaculate, and available time before treatment. For many post-pubertal males, sperm cryopreservation is the standard first-line option and is strongly supported in guidelines ASCO fertility preservation guideline.

1. Sperm banking (sperm cryopreservation)

This is the most established fertility-preservation method for adolescent and adult males who can produce a sample. Semen is collected, analyzed, frozen, and stored for future use. Even a single sample may be valuable, although multiple samples can improve future flexibility.

2. Assisted collection methods

If masturbation is difficult because of pain, stress, cultural concerns, disability, or urgent timing, other methods may sometimes be considered. Depending on the case, centers may offer assisted ejaculation techniques or sperm retrieval procedures.

3. Testicular sperm extraction or retrieval

In selected men who cannot ejaculate or who have no sperm in the ejaculate but may still have intratesticular sperm, surgical retrieval may be considered. This is case-specific and typically coordinated with reproductive urology.

4. Testicular tissue cryopreservation

For prepubertal boys, standard sperm banking is not possible because mature sperm are not yet being produced. Experimental approaches such as testicular tissue cryopreservation may be offered in research settings at some centers. The field remains investigational.

5. Shielding and treatment planning

When feasible, treatment teams may use approaches to reduce gonadal exposure, such as testicular shielding during radiation. This does not eliminate risk in all cases and must never compromise cancer control, but treatment planning can matter.

Comparison of Fertility Preservation Options

Option	Who It's For	When It's Used	Main Considerations
Sperm cryopreservation	Post-pubertal adolescents and adult men	Usually before treatment	Most established option; time-sensitive but often fast to arrange
Assisted ejaculation methods	Men unable to provide standard semen sample	Before treatment when feasible	Availability varies by center
Testicular sperm retrieval	Selected men with ejaculatory issues or azoospermia	Before or after treatment in specific cases	Requires specialist evaluation
Testicular tissue cryopreservation	Prepubertal boys	Before gonadotoxic therapy	Investigational, not standard clinical fertility preservation
Observation with later reassessment	Men with lower-risk treatment or those who decline preservation	During survivorship	Does not protect fertility in advance; relies on later recovery

Treatment and Management After Treatment

If fertility problems arise after cancer treatment, management depends on what exactly has been affected.

Common post-treatment approaches

Repeat semen analysis to check whether sperm production is recovering
Hormone evaluation for testosterone deficiency or pituitary issues
Referral to reproductive urology for azoospermia, ejaculatory dysfunction, or complex cases
Assisted reproductive technology such as IVF or ICSI when sperm numbers are low or surgically retrieved sperm are needed
Sexual medicine support if erectile or ejaculatory problems are present
Psychological support because fertility concerns can affect mood, identity, and relationships

Some men recover sperm production naturally over time. Others may remain infertile but still have options through previously banked sperm, surgical sperm retrieval, donor sperm, or other family-building pathways. Recovery timelines vary substantially by treatment exposure.

A note on testosterone therapy

Men with low testosterone after treatment may need endocrine or urologic evaluation. However, exogenous testosterone can suppress sperm production, so treatment decisions should be individualized if fertility is still a goal. This is an important conversation to have with a specialist rather than self-treating.

Why Timing Is Critical

Timing is one of the most important ideas in oncofertility. The window before cancer treatment can be short, but it is often the best moment to preserve future reproductive options.

Baseline fertility may already be impaired, so delaying can reduce what can be preserved.
Even one treatment cycle may affect sperm quality.
Logistics usually move quickly; many sperm banking programs can coordinate urgent collection.
Future recovery is uncertain; some men recover, others do not.

If treatment cannot be delayed, that does not mean the conversation is over. It means the plan may shift toward post-treatment assessment and tailored reproductive support.

Questions to Ask Your Doctor

If cancer treatment is approaching and fertility matters to you, these questions can make the conversation more productive:

Will my cancer or treatment plan affect my fertility or testosterone?
Should I bank sperm before treatment starts?
How much time do I have to preserve fertility before therapy begins?
Do I need a semen analysis now?
Are there assisted collection options if I cannot provide a sample easily?
Will radiation be near the testes, pelvis, or brain?
Could surgery affect ejaculation or reproductive function?
When should I recheck fertility after treatment?
Should I see a reproductive urologist or fertility specialist?
Are there any reasons I should delay trying to conceive after treatment?

Common Myths and Misconceptions

Myth: If I can have sex normally, I must still be fertile.

Not necessarily. Erectile function, libido, and fertility are related but different. A man can have normal erections and still have severe sperm-production problems.

Myth: Only older men need to think about oncofertility.

False. Adolescents and young adults are often the group most affected by future fertility loss, and preservation decisions are frequently time-sensitive.

Myth: Having one testicle means I will be infertile.

Not always. Many men with one healthy testicle can still produce sperm and testosterone. The bigger picture includes baseline fertility and whether additional treatments were given.

Myth: Fertility preservation always delays cancer treatment.

Usually not by much, and sometimes not at all. Sperm banking can often be arranged quickly. The oncology team balances urgency and safety.

Myth: If semen analysis is abnormal after treatment, recovery is impossible.

Not necessarily. Recovery can occur months or years later depending on the treatment exposure and individual factors.

Semen analysis — lab test that examines sperm count, movement, shape, and semen volume
Azoospermia — no sperm seen in the ejaculate
Oligospermia — low sperm concentration
FSH and LH — pituitary hormones involved in testicular function
Total testosterone — key male sex hormone
ICSI — intracytoplasmic sperm injection, often used when sperm numbers are very low
Cryopreservation — freezing tissue, sperm, or cells for future use
Reproductive urologist — specialist in male fertility and reproductive surgery

Frequently Asked Questions

Can cancer make you infertile before treatment starts?

Yes. Some cancers, especially testicular cancer and certain blood cancers, may reduce semen quality even before therapy begins.

Is sperm banking recommended before chemotherapy?

Often, yes. For post-pubertal males who may receive gonadotoxic treatment, sperm banking before therapy is one of the most established fertility-preservation options.

How many sperm samples should be banked?

It varies. Even one sample can be useful, but multiple samples may provide more flexibility for future assisted reproduction.

Can fertility come back after chemotherapy?

Sometimes. Recovery may happen over months or years, but it depends on the drugs used, cumulative dose, age, and baseline testicular function.

Does low testosterone mean I'm infertile?

Not automatically. Low testosterone and infertility can overlap, but they are not the same diagnosis. Both need proper evaluation.

What if I can't produce a semen sample before treatment?

Ask quickly about alternatives. Depending on the situation, some centers may offer assisted ejaculation methods or sperm retrieval procedures.

Can boys who have not reached puberty preserve fertility?

Standard sperm banking is not possible before puberty. In some centers, investigational approaches such as testicular tissue cryopreservation may be discussed.

When should I see a fertility specialist after cancer treatment?

If you plan to have children, have abnormal semen results, symptoms of low testosterone, ejaculatory problems, or uncertainty about your fertility status, it is reasonable to ask for referral.

Is it safe to try for pregnancy right after cancer treatment?

The answer depends on the treatment and individual circumstances. You should ask your oncology and fertility team for specific guidance on timing.